QSAR and classification models of a novel series of COX-2 selective inhibitors: 1, 5-diarylimidazoles based on support vector machines

H. X. Liu, R. S. Zhang, X. J. Yao, M. C. Liu, Z. D. Hu, B. T. Fan

Research output: Contribution to journalArticlepeer-review

41 Citations (Scopus)

Abstract

The support vector machine, which is a novel algorithm from the machine learning community, was used to develop quantitation and classification models which can be used as a potential screening mechanism for a novel series of COX-2 selective inhibitors. Each compound was represented by calculated structural descriptors that encode constitutional, topological, geometrical, electrostatic, and quantum-chemical features. The Heuristic method was then used to search the descriptor space and select the descriptors responsible for activity. Quantitative modelling results in a nonlinear, seven-descriptor model based on SVMs with root mean-square errors of 0.107 and 0.136 for training and prediction sets, respectively. The best classification results are found using SVMs: the accuracy for training and test sets is 91.2% and 88.2%, respectively. This paper proposes a new and effective method for drug design and screening.

Original languageEnglish
Pages (from-to)389-399
Number of pages11
JournalJournal of Computer-Aided Molecular Design
Volume18
Issue number6
DOIs
Publication statusPublished - Jun 2004
Externally publishedYes

Keywords

  • COX-2 selective inhibitors
  • Classification
  • Drug design
  • Drug screening
  • QSAR
  • SVM

Fingerprint

Dive into the research topics of 'QSAR and classification models of a novel series of COX-2 selective inhibitors: 1, 5-diarylimidazoles based on support vector machines'. Together they form a unique fingerprint.

Cite this